Michael J Seckl (Michael Seckl, M J Seckl)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Ulcerative Colitis

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Scientific reports

Nature communications

NPJ genomic medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Harika Yumru Celiksoy, Catriona Dickie, Michael J Seckl, Esra Aydin, Hamdullah Sozen, Samet Topuz, Christina Fotopoulou
Effectiveness of adjuvant systemic therapy following complete cytoreductive surgery in patients with recurrent granulosa cell tumours of the ovary. Scientific reports 14 (1) (2024)
Harika Yumru Celiksoy, Catriona Dickie, Michael J Seckl, Esra Aydin, Hamdullah Sozen, Samet Topuz, Christina Fotopoulou
Effectiveness of adjuvant systemic therapy following complete cytoreductive surgery in patients with recurrent granulosa cell tumours of the ovary. Scientific reports 14 (1) (2024)
Harika Yumru Celiksoy, Catriona Dickie, Michael J Seckl, Esra Aydin, Hamdullah Sozen, Samet Topuz, Christina Fotopoulou
Effectiveness of adjuvant systemic therapy following complete cytoreductive surgery in patients with recurrent granulosa cell tumours of the ovary. Scientific reports 14 (1) (2024)
Yakinthi Chrisochoidou, Rajat Roy, Pooyeh Farahmand, Guadalupe Gonzalez, Jennifer Doig, Lukas Krasny, Ella F Rimmer, Anne E Willis, Marion MacFarlane, Paul H Huang, Neil O Carragher, Alison F Munro, Daniel J Murphy, Kirill Veselkov, Michael J Seckl, Miriam F Moffatt, William O C Cookson, Olivier E Pardo
Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. Cell death & disease 14 (11) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Lindsay Hennah, Michael J Seckl, Ehsan Ghorani
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Lindsay Hennah, Michael J Seckl, Ehsan Ghorani
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Ulrika Joneborg, Alice Bergamini, Emelie Wallin, Giorgia Mangili, Olesya Solheim, Gloria Marquina, Antonio Casado, Erik Rokkones, John Coulter, Christianne A R Lok, Nienke van Trommel, Frédéric Amant, Pierre-Adrien Bolze, Jalid Sehouli, Sileny N Han, Frédéric Kridelka, Frederic Goffin, Patricia Pautier, Isabelle L Ray-Coquard, Michael J Seckl
European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (10) (2023)
Alice Bergamini, Ramya Ramaswami, Fieke Froeling, Panos Papanastasopoulos, Dee Short, Xianne Aguiar, Philip M Savage, Naveed Sarwar, Baljeet Kaur, Srdjan Saso, Christina Fotopoulou, Anand Sharma, Gordon John Sampson Rustin, Michael J Seckl
Fertility outcomes following surgery and multiagent chemotherapy in malignant ovarian germ cell tumor survivors: a survey study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (11) (2023)
Lindsay Hennah, Michael J Seckl, Ehsan Ghorani
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Johnathan K Joffe, Fay H Cafferty, Laura Murphy, Gordon J S Rustin, Syed A Sohaib, Rhian Gabe, Sally P Stenning, Elizabeth C James, Dipa Noor, Simona Wade, Francesca Schiavone, Sarah Swift, Elaine Dunwoodie, Marcia Hall, Anand Sharma, Jeremy P Braybrooke, Jonathan Shamash, John Logue, Henry H Taylor, Ivo Hennig, Jeff White, Sarah Rudman, Jane Worlding, David J Bloomfield, Guy Faust, Hilary Glen, Rachel Jones, Michael J Seckl, Graham MacDonald, Thiagarajan Sreenivasan, Satish Kumar, Andrew S Protheroe, Ramachandran Venkitaraman, Danish Mazhar, Victoria Coyle, Martin Highley, Tom Geldart, Robert Laing, Richard S Kaplan, Robert A Huddart, null null
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, Michael J Seckl
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 13 (1) (2022)
Geoffrey J Maher, Rosemary A Fisher, Baljeet Kaur, Xianne Aguiar, Preetha Aravind, Natashia Cedeno, James Clark, Debbie Damon, Ehsan Ghorani, Adam Januszewski, Foteini Kalofonou, Ravindhi Murphy, Rajat Roy, Naveed Sarwar, Openshaw M R, Michael J Seckl
Sensitive screening of single nucleotide polymorphisms in cell free DNA for diagnosis of gestational tumours. NPJ genomic medicine 7 (1) (2022)
Marina Georgiou, Panagiota Ntavelou, William Stokes, Rajat Roy, Geoffrey J Maher, Tsvetana Stoilova, Josephine A M Y Choo, Callum P Rakhit, Miguel Martins, Paul Ajuh, Neil Horowitz, Ross S Berkowitz, Kevin Elias, Michael J Seckl, Olivier E Pardo
ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. Oncogene 41 (18) (2022)
Stelios Chrysostomou, Rajat Roy, Filippo Prischi, Lucksamon Thamlikitkul, Kathryn L Chapman, Uwais Mufti, Robert L Peach, Laifeng Ding, David C Hancock, Christopher Moore, Miriam Molina-Arcas, Francesco Mauri, David James Pinato, Joel M Abrahams, Silvia Ottaviani, Castellano L, Georgios Giamas, Jennifer Pascoe, Devmini Moonamale, Sarah J Pirrie, Claire Gaunt, Lucinda Billingham, Neil M Steven, Michael Cullen, David Hrouda, Mathias Winkler, John Post, Philip Cohen, Seth J Salpeter, Vered Bar, Adi Zundelevich, Shay Golan, Dan Leibovici, Romain Lara, David R Klug, Sophia N Yaliraki, Mauricio Barahona, Yulan Wang, Julian Downward, J Mark Skehel, Maruf M U Ali, Michael J Seckl, Olivier E Pardo
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer. Science translational medicine 13 (602) (2021)